LeMaitre Vascular, Inc.
LMAT
$82.59
-$0.21-0.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 61.05M | 64.23M | 59.87M | 55.72M | 54.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 61.05M | 64.23M | 59.87M | 55.72M | 54.82M |
| Cost of Revenue | 15.09M | 19.26M | 18.45M | 17.13M | 17.64M |
| Gross Profit | 45.96M | 44.97M | 41.42M | 38.59M | 37.18M |
| SG&A Expenses | 22.67M | 25.29M | 24.70M | 22.12M | 20.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 40.73M | 48.09M | 47.25M | 42.86M | 41.67M |
| Operating Income | 20.31M | 16.14M | 12.63M | 12.85M | 13.15M |
| Income Before Tax | 22.57M | 18.07M | 14.24M | 14.02M | 14.55M |
| Income Tax Expenses | 5.21M | 4.29M | 3.23M | 2.84M | 3.41M |
| Earnings from Continuing Operations | 17.36M | 13.78M | 11.01M | 11.18M | 11.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 17.36M | 13.78M | 11.01M | 11.18M | 11.14M |
| EBIT | 20.31M | 16.14M | 12.63M | 12.85M | 13.15M |
| EBITDA | 22.93M | 18.79M | 15.18M | 15.33M | 15.57M |
| EPS Basic | 0.77 | 0.61 | 0.49 | 0.50 | 0.50 |
| Normalized Basic EPS | 0.62 | 0.50 | 0.39 | 0.39 | 0.40 |
| EPS Diluted | 0.75 | 0.60 | 0.48 | 0.48 | 0.49 |
| Normalized Diluted EPS | 0.58 | 0.49 | 0.39 | 0.38 | 0.40 |
| Average Basic Shares Outstanding | 22.66M | 22.61M | 22.57M | 22.51M | 22.48M |
| Average Diluted Shares Outstanding | 24.39M | 22.89M | 22.90M | 22.90M | 22.84M |
| Dividend Per Share | 0.20 | 0.20 | 0.20 | 0.16 | 0.16 |
| Payout Ratio | 26.12% | 32.80% | 41.02% | 32.19% | 32.28% |